Closure of patent foramen ovale: When and how?

Current Vascular Pharmacology

Volumn 5, Issue 4, 2007, Pages 322-327

  Lisignoli, Veronica ^a   Lanzone, Alberto M ^b   Zavalloni, Dennis ^a   Pagnotta, Paolo ^a   Presbitero, Patrizia ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b Casa Di Cura Privata Clinica San Rocco Di Franciacorta Spa   (Italy)

Author keywords

Anatomical classification; Cryptogenic stroke; Patent foramen ovale; Transesophageal echocardiography

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ARTERIOVENOUS SHUNT; CEREBROVASCULAR ACCIDENT; DECOMPRESSION SICKNESS; DISEASE ASSOCIATION; DYSPNEA; EMBOLISM; FALSE ANEURYSM; HEART ATRIUM ARRHYTHMIA; HEART SURGERY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; MIGRAINE WITH AURA; NEUROLOGIC DISEASE; PATENT FORAMEN OVALE; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; RECURRENT DISEASE; REVIEW; RISK FACTOR; SECONDARY PREVENTION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; TREATMENT INDICATION; ANOXIA; ARTICLE; DIVING; ECHOGRAPHY; EQUIPMENT; FEMALE; HEART CATHETERIZATION; MALE; MIDDLE AGED; PROSTHESES AND ORTHOSES; STROKE; SYNDROME; TREATMENT OUTCOME;

ANOXIA; DECOMPRESSION SICKNESS; DIVING; DYSPNEA; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EMBOLISM; EQUIPMENT FAILURE; FEMALE; FORAMEN OVALE, PATENT; HEART CATHETERIZATION; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; MIGRAINE WITH AURA; PLATELET AGGREGATION INHIBITORS; PROSTHESES AND IMPLANTS; RECURRENCE; STROKE; SYNDROME; TREATMENT OUTCOME;

EID: 38449093244     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016107782023370     Document Type: Review

References (30)

1. Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, Hier DB, Price TR, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989; 25: 382-390.
2. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002; 105: 2625-2631.
3. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med 2003; 139: 753-760.
4. Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seller C, et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004; 44: 750-758.
5. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000; 356: 1648-1651.
6. Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004; 291: 427-434.
7. Schwerzmann M, Nedeltchev K, Lagger F, Mattle HP, Windecker S, Meier B, et al. Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 2005; 65: 1415-1418.
8. Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla VG. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 1999; 52: 1622-1625.
9. Post MC, Thijs V, Herroelen L, Budts WI. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 2004; 62: 1439-1440.
10. Del Sette M, Angeli S, Leandri M, Ferriero G, Bruzzone GL, Finocchi C, et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis 1998; 8: 327-330.
11. Azarbal B, Tobis J, Suh W, Chan V, Dao C, Gaster R. Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J Am Coll Cardiol 2005; 45: 489-492.
12. Reisman M, Christofferson RD, Jesurum J, Olsen JV, Spencer MP, Krabill KA, et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005; 45: 492-495.
13. Sztajzel R, Genoud D, Roth S, Mermillod B, Le Floch-Rohr J. Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis 2002; 13: 102-106.
14. Morandi E, Anzola GP, Angeli S, Melzi G, Onorato E. Transcatheter closure of patent foramen ovale: a new migraine treatment? J Interv Cardiol 2003; 16: 39-42.
15. Schwerzmann M, Wiher S, Nedeltchev K, Mattle HP, Wahl A, Seller C, et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004; 62: 1399-1401.
16. Tsimikas S. Transcatheter closure of patent foramen ovale for migraine prophylaxis: hope or hype? J Am Coll Cardiol 2005; 45: 496-498.
17. http://www.theheart.org/viewArticle.do?primaryKey=486111&from=/ searchLayout.do.
18. Rao PS, Palacios IF, Bach RG, Bitar SR, Sideris EB. Platypnea-orthodeoxia: management by transcatheter buttoned device implantation. Catheter Cardiovasc Interv 2001; 54: 77-82.
19. Sorrentino M, Resnekov L. Patent foramen ovale associated with platypnea-orthodeoxia. Chest 1991; 100: 1157-1158.
20. Seward JB, Hayes DL, Smith HC, Williams DE, Rosenow EC 3rd, Reeder GS, et al. Platypnea-orthodeoxia: clinical profile, diagnostic workup, management, and report of seven cases. Mayo Clin Proc 1984; 59: 221-231.
21. Guerin P, Lambert V, Godart F, Legendre A, Petit J, Bourlon F, et al. Transcatheter closure of patent foramen ovale in patients with platypnea-orthodeoxia: results of multicentric French registry. Cardiovasc Intervent Radiol 2005; 28: 164-168.
22. Delgado G, Inglessis I, Martin-Herrero F, Yoerger D, Liberthson R, Buoanno F, et al. Management of platypnea-orthodeoxia syndrome by transcatheter closure of atrial communication: hemodynamic characteristics, clinical and echocardiographic outcome. J Invasive Cardiol 2004; 16: 578-582.
23. Germonpre P, Dendale P, Unger P, Balestra C. Patent foramen ovale and decompression sickness in sports divers. J Appl Physiol 1998; 84: 1622-1626.
24. Moon RE, Camporesi EM, Kisslo JA. Patent foramen ovale and decompression sickness in divers. Lancet 1989; 1: 513-514.
25. Barratt DM, Harch PG, Van Meter K. Decompression illness in divers: a review of the literature. Neurologist 2002; 8: 186-202.
26. Schwerzmann M, Seiler C, Lipp E, Guzman R, Lovblad KO, Kraus M, et al. Relation between directly detected patent foramen ovale and ischemic brain lesions in sport divers. Ann Intern Med 2001; 134: 21-24.
27. Knauth M, Ries S, Pohimann S, Kerby T, Forsting M, Daffertshofer M, et al. Cohort study of multiple brain lesions in sport divers: role of a patent foramen ovale. BMJ 1997; 314: 701-705.
28. Walsh KP, Wilmshurst PT, Morrison WL. Transcatheter closure of patent foramen ovale using the Amplatzer septal occluder to prevent recurrence of neurological decompression illness in divers. Heart 1999; 81: 257-261.
29. Germonprè P. Patent foramen ovale and diving. Cardiol Clin 2005; 23: 97-104.
30. Rea TS, Billinger M, Schwerzmann M, Vogel R, Zbinden R, Windecker S, et al. Risk of decompression illness among 230 divers in relation to the presence and size of patent foramen ovale. Eur Heart J 2004; 25: 1014-1020.